HERCULES, CA, September 2, 2008 – Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, announced today the availability of a bulletin (number 5521), entitled “Bio-Plex® Immunoglobulin Isotyping Assays,” which describes the various elements of the Bio-Plex Pro™ human isotyping panel.
The Bio-Plex Pro human isotyping panel allows detection of IgG1, IgG2, IgG3, IgG4, IgA, IgE, and IgM and is the only kit that allows detection of these seven immunoglobulins in a single multiplex assay. The panel offers:
· Multiplex analysis of Ig isotypes in one 96-well plate
· Easy assay preparation and analysis
· Controls for generating QC samples
· Compatibility with standard or magnetic assay preparation methods The kit is for research use only.
The two-page bulletin includes methodology as well as a comprehensive, itemized human assay ordering guide
Availability For a current listing of Bio-Plex Pro human immunoglobulin isotyping assays, visit the Bio-Rad website at www.bio-rad.com/bio-plex/.
The bulletin (number 5521) is available either from a local Bio-Rad sales office or it may be requested by visiting the Bio-Rad web site at http://www.bio-rad.com. To obtain a copy, simply type the bulletin title or number into the search box located at the top-right of the home page.
About Bio-Rad Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs approximately 6,300 people globally and had revenues approaching $1.5 billion in 2007. For more information, visit www.bio-rad.com.
For more information contact: Sergey Vlasenko Bio-Rad Laboratories, Inc. 510-741-5679 Sergey_Vlasenko@bio-rad.com
